Pharmaceutical compositions for the treatment of capillary arteriopathy

Details for Australian Patent Application No. 2007324706 (hide)

Owner Ergonex Pharma GmbH

Inventors Horowski, Reinhard; Reiter, Rudolf; Tack, Johannes

Agent Freehills

Pub. Number AU-A-2007324706

PCT Pub. Number WO2008/061805

Priority 06024308.6 23.11.06 EP; 06025263.2 06.12.06 EP

Filing date 23 November 2007

Wipo publication date 29 May 2008

International Classifications

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 31/00 (2006.01)

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/061805 Priority application(s): WO2008/061805

25 June 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 May 2009

11 November 2010 Assignment before Grant

  Ergonex Pharma GmbH The application has been assigned to Pfizer, Inc. Assignments before Grant, Section 113

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007324721-Process for preparing alkyl (meth)acrylates using an enzymatic cyanohydrin hydrolysis

2007324705-Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production